Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02438956 · ClinicalTrials.gov registry record · NA
Oral Glutathione Supplementation in Older Healthy Adults and Its Effect on the Number of Healthy Days Experienced During Four Months of Supplementation Compared to Placebo
A NA study, sponsored by University of Florida.
- Completed
- Registry status
- NA
- Development phase
- 124
- Enrollment target
NCT02438956 is a NA study that has completed, run by University of Florida. The registered enrollment target is 124 participants.
The verdict
NCT02438956, a NA study, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- NA
- Development phase
- 124 participants
- Enrollment target
Study Summary
A randomized, double blind placebo-controlled parallel intervention in adults over the age of 50 will be performed. Participants will receive a supplement capsule containing placebo (Crystalline Cellulose) or 500mg of Setria® Glutathione to eat for 120 days. Glutathione is hypothesized to replenish the body's reserves that may be depleted through natural aging process, poor diet, or due to the detoxification process for drugs. The primary end point is the number of healthy days experienced during the duration of the study. Secondary endpoints include cellular and biochemical measures from blood samples taken before and after the study.
Interventions
- DIETARY_SUPPLEMENT Setria glutathione supplement
- DIETARY_SUPPLEMENT Crystalline Cellulose
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 124 participants |
| Start Date | 2015-10 |
| Est. Completion | 2017-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02438956
The ClinicalTrials.gov registry entry for NCT02438956 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 124 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Setria glutathione supplement is the first listed.
NCT02438956 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02438956 about?
NCT02438956 is a clinical study titled "Oral Glutathione Supplementation in Older Healthy Adults and Its Effect on the Number of Healthy Days Experienced During Four Months of Supplementation Compared to Placebo". A randomized, double blind placebo-controlled parallel intervention in adults over the age of 50 will be performed. Participants will receive a supplement capsule containing placebo (Crystalline Cellulose) or 500mg of Setria® Glutathione to eat for 120 days. Glutathione is hypothesized to replenish ...
What is the current status of trial NCT02438956?
This trial is currently completed. It is a NA study. The enrollment target is 124 participants. The study started on 2015-10. Estimated completion is 2017-09.
What interventions are being tested in trial NCT02438956?
The interventions under investigation include: Setria glutathione supplement (DIETARY_SUPPLEMENT), Crystalline Cellulose (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02438956?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.